Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M707988200 on March 3, 2008

J. Biol. Chem., Vol. 283, Issue 18, 12489-12500, May 2, 2008
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/18/12489    most recent
M707988200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yan, G.
Right arrow Articles by Cheng, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yan, G.
Right arrow Articles by Cheng, H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Sequestration of NF-{kappa}B Signaling Complexes in Lipid Rafts Contributes to Repression of NF-{kappa}B in T Lymphocytes under Hyperthermia Stress*

Guang Yan{ddagger}§1, Jiannan Huang{ddagger}§1, Nancy Ruth Jarbadan§, Yixing Jiang{ddagger}§, and Hua Cheng{ddagger}§2

From the {ddagger}Department of Medicine, Microbiology and Immunology, and §Penn State Cancer Institute, Penn State University College of Medicine, Hershey, Pennsylvania 17033

Received for publication, September 24, 2007 , and in revised form, February 19, 2008.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Sepsis causes extensive apoptosis of lymphocytes, a pathological condition that is frequently associated with hyperthermia. Heat stress has been implicated to repress the activation of an inflammatory mediator, nuclear factor of {kappa}B (NF-{kappa}B), which sensitizes cells to apoptosis mediated by inflammatory cytokine, tumor necrosis factor {alpha}. However, the molecular mechanism of hyperthermia-associated loss of T cells remains unclear. We show that hyperthermia causes rapid translocation of I{kappa}B kinase (IKK) and NF-{kappa}B complexes into the plasma membrane-associated lipid rafts in T cells. Heat stress induces aggregation of Carma1 in lipid rafts, which in turn recruits protein kinase C{theta} (PKC{theta}) and Bcl10 to the microdomains, causing subsequent membrane translocation of the IKK and NF-{kappa}B signalosomes. Depletion of Carma1 and inhibition of PKC{theta} impair accumulation of NF-{kappa}B complexes in lipid rafts. Heat stress prohibits I{kappa}B kinase activity by sequestrating the IKK and NF-{kappa}B complexes in lipid rafts and by segregating the chaperone protein Hsp90, an essential cofactor for IKK, from the IKK complex. This process ultimately results in functional deficiency of NF-{kappa}B and renders T cells resistant to tumor necrosis factor {alpha}-induced activation of IKK, thereby contributing to the apoptotic loss of T lymphocytes in sepsis-associated hyperthermia.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Bacterial endotoxin in sepsis stimulates immune cells to produce abundant pro-inflammatory cytokines such as tumor necrosis factor {alpha} (TNF{alpha})3 and interleukine-1 (IL-1) (1, 2). As the consequence of hyper-inflammation, severe cell and organ injury may occur. One of the characteristic features of sepsis is extensive apoptosis of lymphocytes and gastrointestinal epithelial cells, which is often associated with rising body temperature or hyperthermia. In response to heat stress, Hsp70, a stress-induced chaperone of the Hsp70 family, is markedly elevated to execute cytoprotective functions by rejuvenating damaged and aggregated intracellular proteins (3, 4). Aside from the chaperone function, Hsp70 has been shown to inhibit apoptosis by interfering with the assembly of Apaf-1 apoptosome and by antagonizing the activity of apoptosis-inducing factor (5–7). Contrary to the anti-apoptotic effect of Hsp70, other studies showed that the stress-induced Hsp70 suppresses cell proliferation and sensitizes cells to apoptosis induced by TNF{alpha}, FasL, and TRAIL (TNF-related apoptosis-inducing ligand) (8–11). During sepsis, TNF{alpha} or endotoxin activates NF-{kappa}B, one of the key mediators of inflammation, whereas overexpression of Hsp70 during heat stress was reported to repress the activity of NF-{kappa}B through binding to IKK{gamma}, a regulatory subunit of I{kappa}B kinase (IKK) complex, in promoting apoptosis in certain types of adhesive cell lines (9) Yet, it remains unclear for the molecular mechanism of sepsis/hyperthermia-related loss of lymphocytes, and it is also unknown about the fate of IKK in the early response to hyperthermia before Hsp70 is synthesized.

The transcriptional factor NF-{kappa}B, including multiple subunits consisting of RelA, RelB, c-Rel, p50/p105, and p52/p100, has prominent roles in immune and inflammatory responses (for review, see Refs. 12–14). In resting T cells, NF-{kappa}B is sequestered in the cytoplasm in complex with its inhibitor, I{kappa}B. Upon ligation of T cell receptor (TCR), sequential activation of upstream kinases and signaling molecules transmits the activation signal to the IKK complex, which comprises two catalytic subunits, IKK{alpha} and IKKβ, and one regulatory subunit, IKK{gamma}. Activated IKK{alpha} and IKKβ in turn serine-phosphorylates I{kappa}B, resulting in ubiquitination and proteasomal degradation of I{kappa}B. Consequently, the freed NF-{kappa}B migrates into the nucleus to activate or repress expressions of responsive genes that mediate distinct biological functions. The activity of NF-{kappa}B is essential for T cell activation and proliferation, which requires plasma membrane recruitment of the IKK complex into lipid raft microdomain (15, 16). This membrane recruitment process is critical in TCR-directed activation of NF-{kappa}B. The upstream serine kinase, PKC{theta}, plays an essential role in the process of the membrane translocation of the IKK complex (17, 18). Although PKC{theta} does not directly interact with IKK, an intermediate protein complex comprising Carma1, Bcl10, and MALT1 was demonstrated to be critical to bridge IKK to PKC{theta} upon T cell activation. Depletion of Carma1 retards the membrane translocation of the IKK complex after TCR stimulation (19), whereas Bcl10 activates NF-{kappa}B through ubiquitination of IKK{gamma} (20). These evidences provide critical insights on the roles of PKC{theta}, Carma1, and Bcl10 in TCR-directed activation of IKK and NF-{kappa}B. Lipid rafts are detergent-resistant cholesterol- and glycosphingolipid-enriched plasma membrane domains that can aggregate to form immune synapse upon TCR ligation (21–23). Enrichment of signaling molecules in this structure transmits activation signal to the downstream effector molecules. Although TNF{alpha}-induced activation of NF-{kappa}B can bypass PKC{theta}, this process requires membrane recruitment of the IKK complex and IKK-associated chaperone, Hsp90 (24).

In addition to the native inhibitors of NF-{kappa}B, I{kappa}Bs, and the precursors of NF-{kappa}B1 and NF-{kappa}B2 (p105 and p100 respectively), several cellular factors including PP2Cβ, PP2A, A20, CYLD, hTid-1 (human Tid1), and Hsp70 have been reported to negatively modulate the activity of NF-{kappa}B through inhibition of IKK via distinct mechanisms (9, 25–31). Tid1 and Hsp70 form a molecular chaperone complex (32–34) in which Hsp70 is up-regulated during hyperthermia. Although in primary cells, the level of Hsp70 is low or even undetectable in the absence of stress, Hsp70 is abundantly expressed in most cancer cells, and this deregulated expression or activity is thought to play a prominent role in the process of oncogenesis (35, 36). Intriguingly, NF-{kappa}B is constantly activated in many types of cancer (37–41). Co-existence of the abundance of Hsp70 and the constitutive activity of NF-{kappa}B in cancer cells obviously contradicts the role of Hsp70 as a repressor to the IKK complex. To achieve a sustainable repression of NF-{kappa}B, an excessive amount of Hsp70 appeared to be needed (9). In fact, in most cancer cells the level of Hsp70 is already very high; heat shock does not further increase Hsp70 to a significantly higher level. Yet, the repression of NF-{kappa}B in heat-stressed cancer cells still occurs. Furthermore, we reproducibly observed that the repression of NF-{kappa}B took place immediately upon heat stress in T cells before de novo synthesis of Hsp70. These data imply that other events in addition to Hsp70 may play a role in the suppression of NF-{kappa}B during the physiological response to hyperthermia. In this study we explored the molecular mechanism of hyperthermia-associated repression of NF-{kappa}B in T cells. We found that heat stress caused rapid aggregation of Carma1 in lipid rafts, leading to subsequent membrane targeting of Bcl10 and PKC{theta} that in turn recruit downstream IKK and NF-{kappa}B signalosomes to the rafts. Sequestration of the IKK and NF-{kappa}B complexes in the lipid rafts and segregation of Hsp90 from the IKK complex lead to the prohibition of IKK, resulting in stabilization of NF-{kappa}B-I{kappa}B{alpha} complex in lipid rafts and a functional deficiency of NF-{kappa}B in T cells under hyperthermia.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Cell Lines, Antibodies, and Reagents—Human T cell lines including MT1, MT2, MT4, TL-Om1, SupT1, Jurkat, J{gamma}1, and P116 were cultured in RMPI1640 medium supplemented with 10% fetal bovine serum plus antibiotics at 37 °C, 5% CO2; the T cell lines OS-P2, FC36 were cultured in the same conditions as above with supplementation of natural IL-2 (10%). SupT1, Jurkat E6-1, P116, and J{gamma}1 cell lines were obtained from the ATCC (Manassas, VA), MT1, MT4, and TL-Om1 were kindly provided by Drs. Atsushi Koito and Takeo Ohsugi (Center for AIDS Research and Institute of Resource Development and Analysis, Kumamoto University). The Carma1-deficient Jurkat variant cell line, JPM50.6, was kindly provided by Dr. Xin Lin (M.D. Anderson Cancer Center, Houston, TX). The following reagent was obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health: FC36.22 from Drs. Fiorenza Cocchi, Anthony DeVico, Alfredo Garzino-Demo, Suresh Arya, Robert Gallo, and Paolo Lusso (50); OS-P2/HTLV-I from Dr. Michael Lairmore (51); MT-2 from Dr. Douglas Richman. Peripheral blood lymphocytes were isolated from buffy coat of healthy blood donor using Ficoll-Hypaque method (GE Healthcare) following the manufacturer's recommended protocol. The freshly isolated peripheral blood lymphocytes were stimulated with phytohemagglutinin (1 µg/ml) for 16 h, and then the cells were washed with RPMI1640 serum-free medium and cultured in the complete RPMI160 media supplemented with I0% natural IL-2 (ZeptoMetrix, Buffalo, NY) for an additional 7 days. After IL-2 stimulation, peripheral blood lymphocytes were cultured in the IL-2 free media for 2 days before heat shock procedure. Non-lymphoid cell lines HT1080 and human fibroblast cell line were obtained from the ATCC, and the mesothelial cell line was established by retroviral transduction of primary mesothelial cells with SV40 large T antigen.

Antibodies reacting to I{kappa}B{alpha}, I{kappa}Bβ, p65, p50, p52, RelB, Bcl10, Hsp70, Hsc70, and Hsp90 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-IKK{alpha}, IKKβ, IKK{gamma}, and serine-phosphorylated I{kappa}B{alpha} were purchased from IMGENEX (San Diego, CA). Anti-Carma1 and anti-phosphorylated IKK{alpha}/β were obtained from Cell Signaling Technology (Danvers, MA). Antibodies to PLC{gamma}1 and ZAP70 were obtained from BD Transduction Laboratories, and LAT was from Upstate Biotechnology (Charlottesville, VA). Anti-β-actin antibody, horseradish peroxidase-conjugated cholera toxin β subunit, methyl-β-cyclodextrin (MβCD), protease and phosphatase inhibitor cocktails, and C6-ceramide were obtained from Sigma. The proteasome inhibitor MG-132 was from Calbiochem.

Mammalian Expression Plasmids—The expression plasmids for GST-tagged I{kappa}B{alpha}, I{kappa}Bβ, p65 RelA, IKK{alpha}, IKKβ, and IKK{gamma} were described previously (31). GST-tagged p50 was also constructed in the pBCAG vector. To generate the wild type of PKC{theta}, the full-length of PKC{theta} was amplified with PCR using Pfu DNA polymerase (Stratagene, La Jolla, CA), and the DNA template was from cDNAs prepared from human lymph node. The PCR fragment of PKC{theta} was digested with HindIII and BamHI and subsequently inserted into the expression vector pCEF with a C-terminal hemagglutinin tag and verified with DNA sequencing analysis. pRK6/Myc-Carma1 construct was provided by Dr. Xin Lin (M.D. Anderson Cancer Center).

Lentivirus Vector and Transduction—The full-length fragments of CD3{zeta}, IKK{alpha}, and IKKβ in the mammalian expression vectors were described previously (31, 52). The EcoRI/HindIII fragment of CD3{zeta} was fused with the HindIII/NotI fragments of either IKK{alpha} or IKKβ followed by ligation with lentivirus vector pLCMV6 that was pre-cut with EcoRI/NotI. The resulting recombinant lentivirus vectors comprised CD3-IKK{alpha} or CD3-IKKβ chimera driven by human cytomegalovirus promoter. A full-length of CD3{zeta} (EcoRI/NotI fragment) was inserted into the same lentivirus vector. The expressions of CD3{zeta} and the CD3-IKK fusion genes were verified by transient transfection in HEK293 cells, and the activities of CD3-IKK were determined by the NF-{kappa}B luciferase reporter assay. To construct a known constitutively active I{kappa}B kinase, a HindIII-XbaI fragment containing the full-length of IKKβ(S177E/S181E) (constitutively kinase-active) in the vector pCMV2-IKKβ(S177E/S181E) (Addgene Inc., Cambridge, MA) was subcloned to the lentivirus vector with the GFP tag at the N terminus to generate GFP-IKKβ(S177E/S181E). This construct was verified with NF-{kappa}B reporter assay, fluorescence imaging, and immunoblot. The lentivirus production and transduction in T cell lines were followed with the procedure described previously (31), and ~10 multiplicity of infection was used for transduction of T cells with high efficiency. The full-length EcoRI/BamHI fragment of LAT derived from pCEF/LAT-FLAG (53) was fused with the enhanced GFP fragment (BamHI/XbaI) followed by insertion in the lentivirus vector that was pre-cut with EcoRI/XbaI. Transduction of MT2 cells was performed by the lentivirus carrying the LAT-GFP fusion gene. Expression of LAT-GFP in stably transduced MT2 cells was verified by visualization with fluorescence imaging and Western blot analysis using anti-GFP or anti-LAT antibody.

Protein Interactions by GST Pulldown—To examine the interaction of PKC{theta} with NF-{kappa}B signaling components in vivo, the PKC{theta} expression plasmid was co-transfected with GST-tagged I{kappa}B{alpha} and I{kappa}Bβ and the subunits of NF-{kappa}B (p65 RelA and p50), IKK{alpha}, IKKβ, or IKK{gamma} into HEK cells using SuperFect transfection reagent (Qiagen, Alencia, CA). 24 h post-transfection the cells were lysed in the Buffer A containing 1% Triton X-100, 40 mM Tris·Cl, pH 7.5, 150 mM NaCl, 2 mM MgCl2, 0.5 mM dithiothreitol, and protease inhibitor mixture at 4 °C for 30 min. Glutathione-Sepharose beads were added into the soluble supernatants, and incubation was at room temperature for 2 h. The beads were then washed 3 times with the lysis buffer and subjected for SDS-PAGE plus Western blot analysis using anti-hemagglutinin (HA) antibody to detect HA-tagged PKC{theta}.

Heat Shock Procedure and Western Blot Analysis—The cells were left untreated or heat-shocked at 43 °C–45 °C/30 min followed by culturing at normal culture conditions (37 °C/5% CO2) for the indicated time points. Cells were collected and lysed in the lysis buffer B containing 40 mM Tris·Cl, pH 7.6, 1% Triton X-100, 150 mm NaCl plus protease and phosphatase inhibitor cocktails at 4 °C for 30 min. The 1% Triton X-100-insoluble pellets were dissolved in the buffer C containing 1% SDS and 40 mM Tris·Cl, pH 8.0. Equal amounts of cellular proteins were analyzed by SDS-PAGE electrophoresis followed by immunoblot. Anti-β-actin blot was used for the protein loading control.

Lipid Raft Fractionation by OptiPrep Density Gradient Ultracentrifugation—Cells (4 x 107) were lysed in 2 ml of extraction buffer (20 mM Tris·Cl, pH 7.4, 150 mm NaCl, 1 mm EDTA, 1% Triton X-100 plus protease inhibitor mixture). Lysates were sheared by 20 passages through a 22-gauge needle, incubated for 20 min on ice before mixing with the OptiPrep density gradient medium (Iodixanol solution, final concentration, 40% vol/vol; AXIS-SHIELD PoC AS, Oslo, Norway), and placed at the bottom of a 12-ml tube. By overlaying 4 ml of 30% and 4 ml of 5% of OptiPrep medium, a discontinuous OptiPrep gradient was formed. Ultracentrifugation was performed at 100,000 x g for 4 h at 4 °C in SW41 rotor. 1 ml of each fraction from top to bottom was collected and subjected to Western blot analysis. Depletion of plasma membrane cholesterol by MβCD in Jurkat T cells was performed by pretreatment of the cells (4 x 107 cells/each sample) with 10 mM MβCD for 45 min at 37 °C in Hanks' balanced salt solution. After this step the cells were left unheated or heat-shocked. 30 min at the normal culture conditions after heat stress, cells were subjected to density gradient ultracentrifugation for lipid raft fractionation analysis. The pretreatment of Jurkat T cells was carried out by adding C6-ceramide (10 µM) into 4 x 107 cells/5 ml of medium for 30 min at 37 °C followed by heat shock procedure.

Fluorescence Imaging—The cells were cultured in a polylysine-treated dish at 37 °C, 5% CO2 for about 20 min. The attached cells were washed with PBS and then fixed in iced methanol:acetone (1:1) for 10 min at room temperature. Then the fixed cells were blocked with the horse serum-blocking solution and incubated with primary antibodies (1:100 in PBS) at 37 °C for 60 min. The cells were washed twice in PBS and then incubated for 30 min at room temperature with goat anti-mouse IgG-fluorescein isothiocyanate diluted 1:500 in PBS and 1 µg/ml Hoechst 33342. The cells were washed 3 times with PBS. Microscopy was performed using Leica TCS SP2 AOBS confocal microscope.

Electrophoretic Mobility Shift Assay—Nuclear extracts were prepared from MT2, Jurkat, and JPM50.6 cells before and after the heat shock procedure and with or without TNF{alpha} stimulation (10 ng/ml for 10 min at 37 °C) using NE-PER nuclear and cytoplasmic extraction reagents (Pierce). The sequence of the oligonucleotide corresponding to the {kappa}B element from IL-2 R{alpha} gene was 5'-gatcCGGCAGGGGAATCTCCCTCTC-3'. The underlined sequence is the {kappa}B cis element. The oligonucleotide was 5'-end-labeled with biotin (Integrated DNA Technologies, Coralville, IA) and annealed to its complementary strand. The NF-{kappa}B binging activity to the {kappa}B element was examined by electrophoretic mobility shift assay (EMSA) using a LightShift chemiluminescent EMSA kit (Pierce). In brief, 5 µg of the nuclear extracts were preincubated in a 20 µl of total reaction volume containing 100 mM Tris, pH 7.5, 500 mM KCl, 10 mM dithiothreitol, 200 mM EDTA, pH 8.0, 50% glycerol, and 1 µg of polydeoxyinosinic-deoxycytidylic acid and 2 µl of biotin-labeled double-stranded probe (20 fmol) for 20 min at room temperature. Then the reactions were mixed with 5 µl of 5x loading buffer and run on a 6% nondenaturing polyacrylamide gel in 0.5x TBE (1x Tris-buffered EDTA: 89 mM Tris borate, 2 mM EDTA, pH 8.3) for 90 min at 100 V on ice. The binding reactions in the gel were transferred to Nylon membrane (Amersham Biosciences) at 380 mA for 1 h in 0.5x TBE on ice. The membrane was cross-linked at 100 mJ/cm2 for 2 min using UV-light cross-linker. Then the biotin-labeled DNA was detected by streptavidin-horseradish peroxidase and chemiluminescence.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Both NF-{kappa}B and I{kappa}B{alpha} Shift from the Cytoplasm into Detergent-resistant Cellular Structure upon Heat Stress—To investigate the role of the stress-induced Hsp70 in hyperthermia, we screened eight T cell lines to identify a model cell system that expresses a low or non-detectable level of Hsp70 at non-stress condition. Such a cell model would ideally produce an abundant amount of Hsp70 upon heat stress, which could imitate the process of physiological response to hyperthermia. An added advantage of this cell model could allow genetic modification in examining potential signaling pathways involved in hyperthermia response. Seven of eight T cell lines produced variable amounts of Hsp70, whereas Hsp70 was not detected in MT1 cells at the normal culture conditions (Fig. 1A). Heat stress (HS) induced a detectable level of Hsp70 2 h post-HS in MT1 cells, and the amount of Hsp70 was further increased for at least 6 h post-HS (Fig. 1B). In contrast, the level of Hsp70 was not altered in heat-stressed MT2 cells (Fig. 1B). The level of the constitutively expressed chaperone Hsc70 remained constant in both MT1 and MT2 cells before- and post-HS (Fig. 1B). Surprisingly, I{kappa}B{alpha}, the inhibitor of NF-{kappa}B, together with the subunits of the NF-{kappa}B heterodimer, RelA (p65) and p50, were depleted in the soluble protein extracts of both MT1 and MT2 cells for at least 6 h post-HS (Fig. 1C, upper panel). The depletions of I{kappa}B{alpha} and NF-{kappa}B were not caused by proteasomal degradation, as such depletions still occurred in the heat-shocked cells that were pretreated with the proteasome inhibitor MG-132. Indeed, the protein levels of I{kappa}B{alpha} and NF-{kappa}B in total protein extracts were not altered; instead, these cytoplasmic proteins shifted for the soluble fraction into detergent-resistant structure (DR) after heat stress (Fig. 1C, lower panel).


Figure 1
View larger version (73K):
[in this window]
[in a new window]

  		FIGURE 1.
NF-{kappa}B-I{kappa}B{alpha} complex shifts from soluble supernatants to detergent-resistant structure upon heat stress. A, basal levels of stress-induced Hsp70 in various T cell lines. Hsp70, Hsp90, and β-actin (protein loading control) from total lysates as examined by Western blot analysis. B, induction of Hsp70 in MT1 or MT2 cell lines after HS at different time points in soluble protein extracts. Hsc70 and β-actin levels before or after HS were also shown. C, the subunits of NF-{kappa}B, p65 and p50, and I{kappa}B{alpha}, but not β-actin, were depleted in both MT1 and MT2 cells in the soluble supernatants, whereas these proteins were accumulated in the DR structure at different time points post-HS. D, a rapid translocation of I{kappa}B{alpha}, NF-{kappa}B1, and p50 and p65 RelA from the cytoplasm (upper panel) to the DR structure (lower panel) in heat-stressed Jurkat T cells at the indicated time points post-HS. The levels of Hsp70 and β-actin were shown in the soluble supernatants. E, induction of Hsp70 in MT1 cells treated with cadmium chloride at (20 µM) at various time points. Protein levels of I{kappa}B{alpha}, p50, and p65 in the soluble supernatants were shown.

 
We next determined whether the shift of I{kappa}B{alpha} and NF-{kappa}Bto the DR structure occurs in the early phase of hyperthermia response. As shown in Fig. 1D, regardless of pretreatment of Jurkat T cells with MG-132, large amounts of I{kappa}B{alpha} and NF-{kappa}B subunits, including p50 and p65, shifted from the soluble fractions into the DR structure as early as 20 min post-HS, whereas the level of Hsp70 remained constant regardless of heat shock. In MT1 cells, I{kappa}B{alpha} and NF-{kappa}B were confined in the DR even when Hsp70 was produced to a high level (Fig. 1, B and C). These results implicated that Hsp70 had no direct effect on the translocation of I{kappa}B{alpha} and NF-{kappa}B subunits into the DR nor did it cause redistribution of the translocated proteins in the DR structure. To verify this notion, we treated MT1 cells with cadmium chloride, which efficiently induced robust synthesis of Hsp70 4 h post-treatment, yet both I{kappa}B{alpha} and NF-{kappa}B (p50 NF-{kappa}B1 and p65 RelA) showed no visible loss in the soluble protein extracts (Fig. 1E). These data clearly indicate that the process of hyperthermia, rather than Hsp70, causes the shift of I{kappa}B{alpha} and NF-{kappa}B from the cytoplasm into the DR structure.

NF-{kappa}B and I{kappa}B{alpha} Are Recruited to the Membrane-associated Lipid Raft Microdomain in T Cells under Hyperthermia—The lipid raft microdomain is the detergent-resistant cholesterol- and glycosphingolipid-enriched membrane (GM1) structure. To verify whether or not I{kappa}B{alpha} and NF-{kappa}B translocate into this structure in heat-stressed T cells, the cellular protein extracts prepared from unheated and heat-shocked MT1 and MT2 cells underwent lipid raft fractionation analysis. In Fig. 2A, the results showed that I{kappa}B{alpha} and the subunits of NF-{kappa}B, p65RelA, and p50 were distributed predominantly in soluble fractions in unheated MT1 cells, although a fraction of p50 preexisted in the lipid raft fractions. However, these molecules shifted into the lipid raft fractions (fractions 4–6) in heat-stressed MT1 cells corresponding to the fractions of GM1 ganglioside (lipid raft marker, detected using horseradish peroxidase-conjugated cholera toxin β subunit).

In MT2 cells heat stress induced a rapid shift of I{kappa}B{alpha} from soluble fractions into the lipid raft fractions (fractions 5 and 6) (Fig. 2B). Notably, a doublet of I{kappa}B{alpha}, with the upper band representing the serine-phosphorylated I{kappa}B{alpha} as resulted from the constitutive hyperactivity of IKK in MT2 cells, was seen in the soluble fractions before HS, whereas only non-phosphorylated I{kappa}B{alpha} was detected in the lipid raft fractions after heat stress, suggesting that the activity of IKK was impaired during hyperthermia (Fig. 2B). Furthermore, rapid translocation of the NF-{kappa}B subunits (p50 and p65) from the soluble fractions into lipid rafts was also observed in the heat-stressed MT2 cells (Fig. 2B), corresponding to the lipid raft biomarkers LAT (fractions 4 and 5) and GM1 fractions (fractions 4–6). These results support the notion that the NF-{kappa}B complex is indeed translocated to the membrane lipid rafts during hyperthermia stress.

I{kappa}B Kinases Are Translocated into Lipid Rafts during Hyperthermia—To investigate the possibility that IKK may be also recruited to the plasma membrane during hyperthermia stress, we performed similar experiments to examine the shifts of I{kappa}B kinases from soluble protein supernatants to the DR structure. Similar to the membrane recruitment of the NF-{kappa}B-I{kappa}B{alpha} complex, all three subunits of the IKK complex, including IKK{alpha}, IKKβ, and IKK{gamma}, translocated from the soluble supernatant fractions into the DR structure in MT1 and Jurkat T cells as early as 20 min after heat shock (Fig. 3, A and B, respectively). Similar to the NF-{kappa}B-I{kappa}B{alpha} complex, the rapid shift of IKK into the DR structure was unlikely caused by Hsp70 since de novo synthesis of Hsp70 required a minimum of 2 h after stress.


Figure 2
View larger version (40K):
[in this window]
[in a new window]

  		FIGURE 2.
The NF-{kappa}B-I{kappa}B{alpha} complex is recruited to the membrane lipid raft microdomain in T cells under hyperthermia. A, the protein extracts from unheated or heat-shocked MT1 cells (4 h post-HS) underwent density gradient ultracentrifugation, and the fractions were collected and analyzed by anti-I{kappa}B{alpha}, anti-p50, and anti-p65 immunoblots. The fractions 4, 5, and 6 are lipid raft fractions, corresponding to the fractions comprising glycosphingolipid GM1 (lipid raft biomarker) as detected by dot blot analysis using cholera toxin-horseradish peroxidase. B, rapid shift of the NF-{kappa}B-I{kappa}B{alpha} complex from soluble fractions to the lipid raft fractions in MT2 cells upon heat stress. The upper first panel showed a doublet of I{kappa}B{alpha} protein in the soluble fractions, which represent serine-phosphorylated form (upper band) and non-phosphorylated form (lower band) of I{kappa}B{alpha} in unheated MT2 cells. The upper second panel showed lipid raft accumulation of the non-phosphorylated I{kappa}B{alpha} in heat-shocked cells. Panels three and four from the top were the immunoblots using anti-phosphoserine-I{kappa}B{alpha} (pI{kappa}B{alpha}). Each fraction was also examined for the levels of p50 and p65. LAT-GFP protein in MT2 cells expressing LAT-GFP was shown in the lipid raft fractions 4–6. GM1 fractions were indicated in the bottom panel.

 


Figure 3
View larger version (74K):
[in this window]
[in a new window]

  		FIGURE 3.
Translocation of the IKK complex into lipid rafts in T cells during hyperthermia. A, the subunits of IKKs were depleted in the soluble protein supernatants after heat stress. MT1 cells were pretreated with MG-132 or DMSO (solvent control) and then left unheated or heat-shocked followed by culturing back at the normal culture conditions for indicated time points. The amounts of Hsp70, IKK{alpha}, IKKβ, IKK{gamma}, and β-actin in the soluble supernatants are shown in the upper panels, whereas the levels of the above molecules in total protein extracts prepared from 1% SDS buffer are shown in the lower panels. B, IKKs rapidly translocated from soluble supernatants (upper panel) to the DR (lower panel) in heat-stressed Jurkat T cells at the time points 20, 40, and 60 min post-HS. C, lipid raft fractionation assay showed lipid raft translocation (fractions 4–6) of IKK{alpha}, IKKβ, and IKK{gamma}, but not Hsp90 nor ERK1 and JNK1, in heat-stressed MT1 cells. Hsp70 was not detected before heat stress and was detected in the soluble fractions 4 h post-HS. D, lipid raft fractionation assay demonstrated the accumulation of IKK{alpha}, IKKβ, and IKK{gamma} in lipid raft fractions (5 and 6) in heat-shocked MT2 cells. Hsp90 remained in the soluble fractions before or post-HS, whereas a small amount of Hsp70 was detected in lipid raft fractions 5 and 6 post-HS.

 
Analysis of heat-stressed MT1 cells with density gradient ultracentrifugation showed that the subunits of IKK shifted from the soluble fractions into lipid raft fractions (fractions 4–6) (Fig. 3C). Hsp70 was not detected in unheated MT1 cells but was induced 4 h after heat shock, yet newly synthesized Hsp70 was largely localized in the soluble fractions (Fig. 3C). Hsp90, a cofactor for the IKK complex, was reported to co-translocate with IKK into the lipid rafts in TNF{alpha}-stimulated cells (24). We found that Hsp90 constitutively localized in the soluble fractions regardless of heat shock (Fig. 3C). The shift of IKKs into lipid rafts appeared to be specific since mitogen-activated protein kinases such as ERK1 and JNK1 remained in the soluble fractions before or after HS (Fig. 3C). In MT2 cells a portion of IKKs was present in the lipid rafts before heat stress, whereas all three subunits of IKK accumulated in the lipid rafts immediately after heat stress (Fig. 3D). Hsp70 was present in the soluble fractions, and a very small amount of Hsp70 was able to relocate to lipid rafts in heat-shocked MT2 cells, whereas Hsp90 remained in the soluble fractions upon heat shock (Fig. 3D). Furthermore, fluorescence imaging analysis showed that both IKK{alpha} and NF-{kappa}B1 p50 were distributed in the cytoplasm, and some of p50 was in the nucleus before heat shock (Fig. 4A). However, both fluorescence signals of IKK{alpha} and p50 accumulated in the plasma membrane after heat stress (Fig. 4A). Double-staining results demonstrated that IKK{alpha} (red) co-localized with LAT (green) in the lipid rafts to yield a yellow cast in the merged picture in heat-stressed T cells (Fig. 4B). Taken together, it can be concluded that the signalosomes of both IKK and NF-{kappa}B are readily translocated into the membrane-associated lipid raft microdomain in T cells in response to heat stress.


Figure 4
View larger version (79K):
[in this window]
[in a new window]

  		FIGURE 4.
Plasma membrane translocation of IKK{alpha} and NF-kB1 p50 by fluorescence imaging. A, single staining of IKK{alpha} and p50 before and after heat shock in MT2 cells. B, double-staining of IKK{alpha} and LAT in MT2/LAT-GFP cells before and after heat stress.

 


Figure 5
View larger version (52K):
[in this window]
[in a new window]

  		FIGURE 5.
The membrane translocation of PKC{theta} in response to heat stress. A, PKC{theta}, but not β-actin, was depleted in the soluble supernatants after heat shock in MT1 cells (panels 1 and 2, respectively), whereas it was accumulated in the DR structure post-HS. B, lipid raft fractionation assay showed that PKC{theta} was able to translocate into the lipid raft fractions (5 and 6) in heat-shocked MT1 and MT2 cells. IB, immunoblot. C, co-precipitation of PKC{theta} with I{kappa}B{alpha} in transfected HEK293 cells using the GST pulldown assay as described under "Experimental Procedures." D, lipid raft fractionation assay showed that I{kappa}B{alpha}, not phospho-I{kappa}Bβ (pI{kappa}Bβ), was able to shift from the soluble fractions into the lipid raft fractions during hyperthermia.

 
PKC{theta} Directs Lipid Raft Recruitments of the NF-{kappa}B-I{kappa}B{alpha} Complex in Hyperthermia—We explored the underlying mechanism of the membrane recruitment of the IKK and NF-{kappa}B complexes during heat stress. In resting T cells PKC{theta} is predominantly localized in the cytoplasm. Upon TCR activation, PKC{theta} can rapidly translocate to the membrane detergent-insoluble region or lipid rafts, which is one of the key molecules that directs the membrane recruitment of the IKK complex upon T cell activation. To determine whether heat stress utilizes a mechanism similar to TCR-mediated membrane recruitment of the IKK complex in T cells, we examined the potential shift of PKC{theta} from the cytoplasm into the DR structure in the stress condition. As shown in Fig. 5A, PKC{theta} was depleted in the soluble protein extracts (panel 1) and was accumulated in the DR structure (panel 3) in response to heat shock regardless of the presence of MG-132. PKC{theta} was rapidly recruited to the lipid rafts in both MT1 and MT2 T cells upon heat stress (Fig. 5B). By examining the interactions of PKC{theta} with the components of the IKK and NF-{kappa}B signalosomes, we found that PKC{theta} predominantly co-precipitated with I{kappa}B{alpha} and much less so with I{kappa}Bβ in co-transfected HEK cells (Fig. 5C), whereas p65 RelA, p50, and three subunits of IKKs did not co-precipitate with PKC{theta} under the same conditions (Fig. 5C). Indeed, I{kappa}B{alpha} shifted to the plasma membrane, whereas I{kappa}Bβ stayed in the soluble fractions during hyperthermia (Fig. 5D), implicating that the membrane recruitment of the NF-{kappa}B-I{kappa}B{alpha} complex is through direct interaction of I{kappa}B{alpha} with PKC{theta}.

Membrane Lipid Raft Recruitment of PKC{theta} during Hyperthermia Is Dependent on Carma1—The membrane recruitment of PKC{theta} typically occurs in T cell activation. The finding that PKC{theta} is targeted to the membrane in heat stress raised a possibility that both hyperthermia and T cell activation share a similar mechanism for the membrane targeting of PKC{theta}. The previous studies showed that the Carma1, Bcl10, and MALT1 complex, which consists of Carma1, Bcl10, and MALT, serves as scaffold proteins to connect IKK to PKC{theta} (42). Carma1 (CARD11) was shown to be critical for activation of NF-{kappa}B in TCR signaling (43), and loss of Carma1 in Jurkat T cells impaired membrane recruitment of PKC{theta}, IKKβ, and Bcl10 upon T cell activation (19, 44), indicating that Carma1 plays an essential role in recruiting IKK to the membrane through PKC{theta}. To examine the role of Carma1 in the lipid raft recruitment of PKC{theta} and IKK upon heat stress, we utilized the Jurkat T cell model and the Carma1-deficient Jurkat variant, JPM50.6 (19). In Jurkat T cells, hyperthermia caused a drastic shift of PKC{theta} and the downstream NF-{kappa}B signaling molecules, including three subunits of IKK (IKK{alpha}, IKKβ, and IKK{gamma}), the NF-{kappa}B heterodimer (p65/50), and I{kappa}B{alpha}, to the lipid rafts (Fig. 6A, fraction 5, corresponding to the fraction containing the lipid raft protein marker, LAT). However, in JPM50.6 cells, PKC{theta} was retained in the soluble fractions after heat shock (Fig. 6B). Consequently, the membrane translocation of the subunits of IKKs, NF-{kappa}B, and I{kappa}B{alpha} was completely retarded in the Carma1-deficient T cells (Fig. 6B). These results strongly indicate that Carma1 plays an essential role for the lipid raft translocation of PKC{theta} in T cells during hyperthermia stress.


Figure 6
View larger version (75K):
[in this window]
[in a new window]

  		FIGURE 6.
Carma1 is critical for membrane recruitment of PKC{theta} and Bcl10 upon heat stress. A, lipid raft fractionation assay showed the accumulation of PKC{theta} and the IKK and NF-{kappa}B-I{kappa}B{alpha} complexes in the lipid rafts (fractions 5 and 6) in Jurkat T cells under hyperthermia. B, in the Carma1-deficient Jurkat variant cell line, JPM50.6, the lipid raft translocations of PKC{theta}, IKKs, and the NF-{kappa}B-I{kappa}B{alpha} were abolished, and these proteins were accumulated in the soluble fractions 8 and 9 after heat shock, as shown by lipid raft fractionation analysis. C, the chemical inhibitor of cholesterol, MβCD, effectively impaired the membrane recruitment of PKC{theta}, IKKs, and I{kappa}B{alpha} in Jurkat T cells with or without heat stress. D, the PKC{theta} inhibitor, C6-ceramide, prevented accumulation of PKC{theta}, IKK{alpha}, IKKβ, p50, and I{kappa}B{alpha} in the lipid rafts during hyperthermia stress. E, accumulation of Carma1 and Bcl10 in lipid rafts in heat-stressed Jurkat T cells, whereas Bcl10 remained in the soluble cytoplasmic fractions in the Carma1-deficient Jurkat variant, JPM50.6 cells, after HS.

 
We next applied the chemical inhibitor of cholesterol, MβCD, which can effectively deplete cholesterol on the plasma membrane, consequently impairing the membrane lipid raft recruitment of signaling molecules such as PKC{theta}. Indeed, pretreatment of T cells with MβCD completely blocked the shift of PKC{theta} from the soluble fractions to the lipid raft fractions. Instead, PKC{theta} accumulated in the non-lipid raft fractions after heat shock (Fig. 6C). Accordingly, IKK{alpha}, IKKβ, IKK{gamma}, p50, and I{kappa}B{alpha} were concentrated in the non-lipid raft fractions (Fig. 6C). Next, we utilized a PKC{theta} inhibitor, C6-ceramide (45). Jurkat cells were pretreated with C6-ceramide (10 µM) for 30 min at 37 °C before heat shock, and the results showed that C6-ceramide impaired accumulation of PKC{theta}, IKK{alpha}, and IKKβ as well as the NF-{kappa}B-I{kappa}B{alpha} complex into the lipid rafts (fraction 5) in response to heat stress (Fig. 6D). These results are in strong support of the crucial role of PKC{theta}, directed by Carma1, in the lipid raft recruitment of the IKK and NF-{kappa}B-I{kappa}B{alpha} complexes under hyperthermia. Furthermore, we determined whether heat stress affects the behavior of Carma1. It has been shown that a portion of Carma1 was found to be constantly associated with lipid rafts (46). We showed that Carma1 was distributed predominantly in soluble fractions in Jurkat T cells before heat stress but was rapidly aggregated in the lipid rafts after heat shock (Fig. 6E). In accordance with the aggregation of Carma1, Bcl10 was shifted to the rafts in Jurkat cells (Fig. 6E). In contrast, Bcl10 remained in the soluble fractions regardless of heat stress in the Carma1-deficient JPM50.6 cells, indicating the accumulation of Carma1 in the rafts is essential for the membrane translocation of Bcl10. Thus, Carma1 is the key player that recruits both PKC{theta} and Bcl10 in promoting membrane translocation of downstream IKK and NF-{kappa}B complexes in T cells under hyperthermia.

Membrane Translocation of PKC{theta} during Heat Stress Is Independent of ZAP70 and PLC{gamma}1—In the proximal signaling events of TCR activation, activation of Lck, the first line of the protein tyrosine kinases, initiates signaling cascade by sequentially activating downstream kinases including ZAP70 and PI3 kinase, which in turn activate PLC{gamma}1. LAT-dependent membrane recruitment of PLC{gamma}1 induces its lipase activity to generate secondary lipid messengers including diacylglycerol, which activates PKCs. To determine whether the membrane translocation of PKC{theta} during hyperthermia is dependent of the proximal factors, we first evaluated a possible membrane accumulation of signaling molecules that is essential in TCR signaling using primary peripheral blood lymphocytes. Heat shock indeed induced a handful shift of PKC{theta} to the lipid rafts, whereas no apparent migration of upstream kinases ZAP70 and PLC{gamma}1 to the lipid rafts was observed in heat-stressed primary lymphocytes (Fig. 7A). Accordingly, the subunits of IKK and NF-{kappa}B1 (p50) as well as the precursor of NF-{kappa}B1, p105, were accumulated in the lipid rafts although these movements were less potent than in established T cell lines (Fig. 7A). Similar to the finding in T cell lines, Hsp90 and ERK1 remained in the soluble fractions regardless of heat stress (Fig. 7A). These results suggest that the membrane translocation of PKC{theta} is independent of its proximal factors such as ZAP70 and PLC{gamma}1.


Figure 7
View larger version (97K):
[in this window]
[in a new window]

  		FIGURE 7.
The membrane translocation of PKC{theta} is independent of ZAP70 and PLC{gamma}1 during hyperthermia. A, lipid raft fractionation assay showed the movement of PKC{theta}, IKKs, and p50/p105, but not ZAP70, PLC{gamma}1, Hsp90 or ERK1, after heat stress in primary lymphocytes. B, in the ZAP70-deficient Jurkat variant, P116, heat stress induced migration of PKC{theta} and IKKs to the lipid raft fractions, corresponding to the lipid raft-bound LAT. C, lipid raft fractionation of the PLC{gamma}1-deficient Jurkat variant, J{gamma}1, showed that the membrane translocation of PKC{theta} and IKKs still occurred in response to heat stress.

 
To examine this notion further, we utilized two Jurkat variant lines, P116 (ZAP70-deficient) and J{gamma}1 (PLC{gamma}1-deficient). As shown in Fig. 7B, the lipid raft fractionation assay demonstrated that the accumulation of PKC{theta} in the lipid rafts after heat stress still occurred in P116 cells, and accordingly, the membrane recruitment of the IKK complex was also seen. These results suggest that although ZAP70 is essential for TCR-directed activation, it is dispensable for hyperthermia-induced membrane translocation of PKC{theta}. Similarly, in PLC{gamma}1-deficient Jurkat variant line, J{gamma}1, heat stress induced robust membrane lipid raft translocation of PKC{theta} as well as the downstream I{kappa}B kinases (Fig. 7C). Furthermore, we found that the essential T cell adaptor protein, LAT, was not tyrosine-phosphorylated in response to heat stress (data not shown). These results strongly indicate that unlike the proximal events of TCR activation, neither ZAP70 nor PLC{gamma}1 plays a crucial role for the membrane targeting of PKC{theta} in the stress condition. Instead, heat stress targets primarily at Carma1 in sequestrating downstream IKK and NF-{kappa}B complexes in lipid rafts.

Hyperthermia Represses the Activity of IKK in Lipid Rafts in T Cells—TCR stimulation induces activation of NF-{kappa}B, whereas heat stress leads to the inhibition of NF-{kappa}B in numbers of solid tumor cell lines. The rapid transition of serine-phosphorylated I{kappa}B{alpha} to the non-phosphorylated form was seen in heat-stressed MT2 T cells (Fig. 3B), indicating that the activity of IKK is compromised. It was noted that the catalytic activity of IKK in the lipid rafts could not be assessed by the in vitro kinase assay because the purification of these kinases from this structure would impair their activities, which certainly affects interpretation of the activation status of IKK in living cells. Because the phosphorylation of I{kappa}B{alpha} on its N-terminal serine residues is exclusively mediated by the catalytic subunits of IKK, utilization of the antibody that reacts specifically on the serine-phosphorylated I{kappa}B{alpha} is a strong indication for the activity of IKK in the lipid rafts in T cells.

We first examined the serine phosphorylation status of I{kappa}B{alpha} in response to TNF{alpha}. In MT1 cells, a very small fraction of total I{kappa}B{alpha} protein was serine-phosphorylated, implicating that IKK was marginally activated (Fig. 8A, upper panel, lane 1). The phosphorylation of I{kappa}B{alpha} was enhanced by TNF{alpha} treatment (Fig. 8A, upper panel, lanes 2 and 3). Surprisingly, the phosphorylation of I{kappa}B{alpha} was completely blocked as early as 30 min post-HS, far before Hsp70 was produced, and I{kappa}B{alpha} was no longer phosphorylated in heat-stressed MT1 cells upon TNF{alpha} stimulation (Fig. 8A, upper panel, lanes 4–6). Moreover, induction of Hsp70 did not lead to re-phosphorylation of I{kappa}B{alpha} in response to TNF{alpha} (Fig. 8A, upper panel, lanes 7–9), suggesting that de novo synthesis of Hsp70 neither suppresses nor rejuvenates the activity of IKK. Furthermore, heat stress caused reduction of I{kappa}B{alpha} in the detergent-soluble supernatants, whereas I{kappa}B{alpha} rapidly shifted into the DR structure or lipid rafts (Fig. 8A, lower panel). Yet the I{kappa}B{alpha} protein in lipid rafts was unable to be phosphorylated by TNF{alpha} treatment in heat-stressed cells (Fig. 8A, lower panel, lanes 4–9), which suggests that the activity of IKK is prohibited under hyperthermia condition. In MT1 cells, ERK1/2 were constitutively activated, as revealed by their specific serine phosphorylation, and heat stress had no effect on the intensity of the phosphorylation of ERK1/2 for at least 6 h post-HS (Fig. 8B). This implies that hyperthermia causes specific repression on IKK but has no inhibitory effect on ERK1/2.

In MT2 cells the I{kappa}B{alpha} protein was low due to its rapid turnover but was stabilized in the cells pretreated with the proteasome inhibitor, MG-132. A vast majority of I{kappa}B{alpha} was serine-phosphorylated in MT2 cells before heat shock, and phorbol 12-myristate 13-acetate/ionomycin (P/I) treatment did not further increase the intensity of the phosphorylated I{kappa}B{alpha} (Fig. 8C, lanes 1–3). Heat stress caused the shift of I{kappa}B{alpha} from the cytoplasm to the lipid rafts as early as 30 min post-HS, and the I{kappa}B{alpha} protein in both soluble supernatants and lipid rafts was in a non-phosphorylated form even with P/I stimulation (Fig. 8C, lanes 4–6). We also found that in MT2 cells, IKK{alpha} were present in the lipid rafts in the phosphorylated forms before heat shock, indicating these kinases were constitutively activated (Fig. 8D). Heat stress induced rapid accumulation of IKK{alpha} in the lipid rafts (Fig. 8D, lower panel) and inhibited the phosphorylation of IKK{alpha} in this structure (Fig. 8D, upper panel). Thus, it is apparent that the process of hyperthermia, not the synthesis of Hsp70, executes a complete blockade of the serine phosphorylation of I{kappa}B{alpha} by rapidly inhibiting the activity of IKK.


Figure 8
View larger version (48K):
[in this window]
[in a new window]

  		FIGURE 8.
Repression of the activity of IKK in lipid rafts in T cells under heat stress. A, MT1 cells were pretreated with MG-132 followed by the TNF{alpha} stimulation at indicated time points (lanes 1–3) or the MG-132-treated cells were heat-shocked and then left in the normal culture condition for 30 min (lanes 4–6) or 4 h (lanes 7–9) followed by the addition of TNF{alpha} for indicated time points. The soluble supernatants (upper panels) were examined for the levels of I{kappa}B{alpha} (upper first), serine-phosphorylated I{kappa}B{alpha} (p-I{kappa}B{alpha}, upper second), Hsp70 (upper third), Hsc70 (upper fourth), and β-actin (upper bottom). The remaining insoluble pellets were dissolved in the 1% SDS buffer (lower panels), which were analyzed with the immunoblots for I{kappa}B{alpha} (lower first) and the phosphorylated I{kappa}B{alpha} (lower bottom). B, MT1 cells were left unheated or heat-shocked for indicated time points. The soluble supernatants were analyzed for anti-phospho-ERK1, Hsp70 and β-actin blots. C, MT2 cells were pretreated with MG-132 followed by the phorbol 12-myristate 13-acetate/ionomycin (P/I, 50 ng/1 µg/ml) stimulation at indicated time points (lanes 1–3), or the MG-132-treated cells were heat-shocked and then left in the normal culture condition for 30 min (lanes 4–6) followed by P/I stimulation for the indicated time points. The total I{kappa}B{alpha} and the serine-phosphorylated I{kappa}B{alpha} in the soluble supernatants (upper panel) and in the DR structure (lower panel) were analyzed. D, IKK{alpha} is phosphorylated in MT2 cells before HS, and heat stress inhibited the phosphorylation of IKK{alpha} in the lipid rafts (fractions 5 and 6). E, CD3{zeta} (lane 1), CD3-IKK{alpha} (lane 2), or CD3-IKKβ (lane 3) was stably expressed in MT2 cells by lentivirus transduction, which was detected by anti-CD3{zeta} blot. ns, nonspecific band. F, MT2 cells expressing CD3{zeta}, CD3-IKK{alpha}, and CD3-IKKβ were left unheated or heat-shocked followed by culturing back into the normal culture conditions for the indicated time points. The upper panel showed anti-I{kappa}B{alpha}, phospho-I{kappa}Bβ (pI{kappa}Bβ), and β-actin blots using soluble supernatants. The lower panel showed the levels of total I{kappa}B{alpha} and pI{kappa}B{alpha} in the DR structure. G, the {kappa}B binding activity of the nuclear extracts from MT2 cells before and after HS. H, the {kappa}B binding activity of the nuclear extracts from MT2 cells exogenously expressing GFP-IKKβ(S177E/S181E) (a constitutively kinase-active form) before and after HS. I, serine phosphorylation of I{kappa}B{alpha} in the MT2/GFP-IKKβ(S177E/S181E) cells, which were pretreated with MG132 before and after HS in response to TNF{alpha} as indicated in the figure. The {kappa}B binding activity of the nuclear extracts from Jurkat T cells (J) and JPM50.6 cells (K) before (lanes 1 and 2) and after HS (lanes 3 and 4) with TNF{alpha} stimulation (lanes 2 and 4).

 


Figure 9
View larger version (36K):
[in this window]
[in a new window]

  		FIGURE 9.
Expression of Carma1 in non-lymphoid cells does not lead to lipid raft translocation of IKK and inhibition of NF-{kappa}B after heat stress. A, lipid raft fractionation analysis of non-lymphoid cell lines HT1080, human fibroblasts (HF) and HM1 (human mesothelial cell line) post-HS. The fractions 4 and 5 are the lipid raft fractions, as indicated by the marker GM1. B, lipid raft fractionation analysis of HT1080 cells expressing GFP-Carma1 before and after HS. C, NF-{kappa}B activity in HT1080/Carma1 cells before (lanes 1 and 2) and after HS (lanes 3 and 4), without TNF{alpha} (lanes 1 and 3), and with TNF{alpha} (lanes 2 and 4) as shown by electrophoretic mobility shift assay.

 
To further examine the notion that the activity of IKK is prohibited in the rafts during hyperthermia, we constructed membrane-targeted chimeras of IKK{alpha} and IKKβ that were fused with CD3{zeta} to generate CD3-IKK{alpha} and CD3-IKKβ, respectively. The fusion of IKK with CD3{zeta} targets IKK to the plasma membrane in the absence of TCR activation or hyperthermia, as it is agreed that a portion of TCR-CD3 clusters localizes in the lipid rafts in quiescent T cells (47). In addition, these chimeras acquired catalytic activities of IKK{alpha} and IKKβ as seen in transfected HEK cells without extracellular and intracellular stimuli (data not shown). In T cells that stably expressed CD3, CD3-IKK{alpha}, or CD3-IKKβ, heat stress resulted in instant suppression of I{kappa}B{alpha} phosphorylation in all three established cell lines (Fig. 8E). The heat-shocked cells were unable to respond to TNF{alpha}-mediated activation of IKK (Fig. 8A). Next, the {kappa}B DNA binding activity of the nuclear extracts before and after heat stress was examined with electrophoretic mobility shift assay. As shown in Fig. 8G, the basal activity of the {kappa}B binding of NF-{kappa}B in MT2 cells was high, and this activity was inhibited after heat stress. In T cells that exogenously express a constitutively kinase-active form of IKKβ (S177E/S181E), heat stress still potently suppressed the activity of NF-{kappa}B and diminished the phosphorylation of I{kappa}B{alpha} (Fig. 8, H and I), and both IKKβ(S177E/S181E) and I{kappa}B{alpha} were shifted into the detergent-resistant structure (Fig. 8I, lower panel). Furthermore, the basal activity of {kappa}B binding was almost undetectable in Jurkat T cells and was readily induced by TNF{alpha} before heat shock (Fig. 8J, lane 2), and heat stress resulted in the unresponsiveness of these cells to TNF{alpha}-induced NF-{kappa}B activity (Fig. 8J, lane 4). Remarkably, the Carma1-deficient, Jurkat variant cells (JPM50.6) responded to TNF{alpha}-induced NF-{kappa}B activity regardless of heat stress (Fig. 8K, lanes 2 and 4). Together, these results indicate that the kinase activity of IKK was impaired under hyperthermia stress in T cells in Carma1-dependent manner, and such repression of IKK can occur in the lipid rafts.

Finally, we tested three non-lymphoid cell lines and found that heat stress did not cause the lipid raft translocation of I{kappa}B kinases (Fig. 9A). To determine whether expression of Carma1 alone in non-lymphoid cells is sufficient to mediate heat stress-induced inhibition of I{kappa}B kinases, we expressed Carma1 into HT1080 cells. We found that expression of Carma1 in HT1080 cells did not lead to the lipid raft translocation of IKK, and these cells still responded to TNF{alpha}-mediated NF-{kappa}B activation (Fig. 9, B and C). These data indicated that Carma1 is a critical determinant for the induction of the lipid raft translocation of NF-{kappa}B signaling complexes in T cells upon heat stress, whereas Carma1 alone is not sufficient to mediate lipid raft translocation and inactivation of NF-{kappa}B in non-lymphoid cells.


Figure 10
View larger version (28K):
[in this window]
[in a new window]

  		FIGURE 10.
A hypothetical model of hyperthermia-induced sequestration of the IKK and NF-{kappa}B complexes. Heat stress primarily targets at Carma1 (1) to induce its aggregation in the rafts (2). The accumulation of Carma1 in the rafts recruits PKC{theta} and Bcl10 to the membrane (3), which in turn bring the downstream IKK and NF-{kappa}B complexes to the lipid rafts (4 and 5), whereas Hsp90, the cofactor for IKK, remains in the cytoplasm. Consequently, the IKK and NF-{kappa}B-I{kappa}B{alpha} complexes are sequestrated in the rafts to maintain inactive forms (6), resulting in functional deficiency of NF-{kappa}B in the nucleus for at least 6 h post-hyperthermia.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
In this study we illustrated a novel mechanism of hyperthermia-associated repression of NF-{kappa}B in T lymphocytes. Heat stress causes rapid membrane lipid raft recruitment and sequestration of the IKK and NF-{kappa}B-I{kappa}B{alpha} complexes. In addition, the segregation of the IKK complex from Hsp90 leads to the prohibition of the activity of IKK, resulting in blockade of the serine phosphorylation of I{kappa}B{alpha} catalyzed by IKK. These coordinated actions suppress the activity of NF-{kappa}B for at least 6 h after heat shock. Heat stress renders T cells resistant to TNF{alpha}-induced activation of IKK (see the hypothetical model in Fig. 10).

Our data showed that Hsp70 does not play a major role in the repression of NF-{kappa}B in the early phase of hyperthermia response in T cells. Although Hsp70 was reported to interact with IKK{gamma}, how this interaction leads to repression of the catalytic subunits of IKKs, IKK{alpha} or IKKβ, remains unsolved. To explore the molecular mechanism of hyperthermia response in T cells, we utilized several T cell model systems that provide dynamic views for the fate of NF-{kappa}B signaling molecules during heat stress. First, Hsp70 is not detected in MT1 cells within 2 h post-HS, so this leaves a 2-h time window for assessing an immediate response to heat stress by excluding potential effects of Hsp70. Second, IKK is constitutively activated, and I{kappa}B{alpha} is serine-phosphorylated in MT2 cells so the repression of IKK can be determined in the earliest stage of hyperthermia response. Third, Jurkat T cell model and its variant cell lines are utilized to determine the key signaling events during hyperthermia. And last, the use of primary lymphocytes provides a physiological relevance of hyperthermia response. We showed that rapid translocation of IKK and the NF-{kappa}B-I{kappa}B{alpha} complexes to the rafts occurs as early as 20 min, and sequestration of these molecules in this compartment persists for at least 6 h post-heat stress. Consequently, the serine phosphorylation of I{kappa}B{alpha} in response to TNF{alpha} stimulation is abolished regardless of the presence of Hsp70. Thus, in contrast to the previous reports for the role of Hsp70 in hyperthermia-associated repression of NF-{kappa}B in adhesive cells, our data indicate that the repression of NF-{kappa}B is not related to Hsp70 in T cells. Rather, hyperthermia induces rapid membrane lipid raft recruitment and sequestration of the IKK and NF-{kappa}B signalosomes in T cells.

We identified PKC{theta} and Carma1 as primary factors directing the membrane recruitment of the IKK and NF-{kappa}B complexes during hyperthermia. By analyzing the signaling molecules recruited to the lipid rafts in T cell activation and hyperthermia, both events depend on Carma1 in recruiting the IKK complex to the plasma membrane. The membrane recruitment of PKC{theta}, Bcl10, and the IKK and NF-{kappa}B signalosomes is completely defective in the Carma1-deficient T cells upon heat stress. Moreover, the cholesterol inhibitor, MβCD, effectively prevents the lipid raft translocation of PKC{theta} from the cytoplasm. Furthermore, C6-ceramide impaired the membrane translocation of PKC{theta}, IKK, and NF-{kappa}B complexes in response to heat stress. Our results showed that heat stress caused aggregation of Carma1 in the lipid rafts, which sequentially recruits PKC{theta}, Bcl10, and the IKK and NF-{kappa}B complexes but not the cofactor Hsp90 to the rafts. These data, therefore, validated the mechanism of Carma1-dependent, PKC{theta}-directed, membrane lipid raft recruitment of the IKK complex upon heat stress in T cells. Although the hyperthermia response in B lymphocytes has not been explored in this study, studies on B cell receptor signaling showed that activation of B cells can recruit IKK to lipid rafts through PKCβ (48), suggesting that a similar scenario to T cells may occur in B cells. Both ZAP70 and PLC{gamma}1 are required for activation of PKC{theta} in TCR activation (49) but are dispensable for the membrane recruitment of PKC{theta} and IKK under the stress condition. Indeed, our data demonstrated that heat stress does not engage TCR; instead this stress process primarily targets at Carma1 in T cells, leading to the membrane recruitment of PKC{theta} and sequestration of the IKK and NF-{kappa}B complexes in lipid rafts.

Opposing TCR-directed membrane recruitment of PKC{theta} and IKK that leads to activation of NF-{kappa}B, hyperthermia stress induces immediate repression of NF-{kappa}B in T cells. One obvious question is how the signal is disrupted at the site of lipid rafts without further transmitting to the downstream in hyperthermia response of T cells. Based on our experimental data, we propose at least two interrelated mechanisms. (a) The first is sequestration of the IKK and NF-{kappa}B complexes in the lipid rafts. This action apparently causes relative deficiency of the NF-{kappa}B molecules for gene activation, which potentiates the apoptotic loss of T cells in response to hyperthermia/TNF{alpha} (data not shown). Unlike a transient nature of the membrane recruitment of IKK in T cell activation, the sequestration of IKK and NF-{kappa}B signaling molecules in the lipid rafts can persist for at least 6 h after heat stress, thereby providing extended period for the repression of NF-{kappa}B. (b) The second is segregation of Hsp90 from the IKK complex. Lipid rafts can serve as the physical shield of the IKK complex from Hsp90 and proteasome. In quiescent T cells, lipid raft-bound Lck is separated from the downstream signaling molecules, and this mode of action prevents spontaneous activation of T cells in a controllable manner. Lipid rafts, therefore, can serve as the physical shield in the resting stage or the melting pot for enrichment of signaling molecules upon T cell activation. Under hyperthermia conditions, Hsp90 remains in the cytoplasm, segregating itself from the IKK complex. Because Hsp90 is an essential cofactor for the IKK complex to maintain active structural conformation of the complex, this segregation leads to inactivation of IKK upon TNF{alpha} stimulation and potentiates the apoptotic death of T cells in response to the proinflammatory cytokines such as TNF{alpha}. Furthermore, the IKK and NF-{kappa}B-I{kappa}B{alpha} complexes in lipid rafts are away from the cytoplasmic proteasome, increasing their stability to maintain an inactive form. Collectively, our study has demonstrated that the mode of these coordinated actions contributes to the hyperthermia-associated repression of NF-{kappa}B and apoptotic loss of T cells during sepsis.


   FOOTNOTES
 
* This work was supported by a fund from Penn State Cancer Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 These authors contributed equally to this work. Back

2 To whom correspondence should be addressed: Penn State Cancer Institute, Oncology Room 6818, 500 University Dr., Hershey, PA17033. Tel.: 717-531-3863; Fax: 717-531-5076; E-mail: hcheng{at}hmc.psu.edu.

3 The abbreviations used are: TNF, tumor necrosis factor {alpha}; IL-1, interleukine-1; JNK, c-Jun N-terminal kinase; P/I, phorbol 12-myristate 13-acetate/ionomycin; IKK, I{kappa}B kinase; TCR, T cell receptor; PKC, protein kinase C; MβCD, methyl-β-cyclodextrin; GST, glutathione S-transferase; GFP, green fluorescent protein; HEK cells, human embryonic kidney cells; PBS, phosphate-buffered saline; HS, heat shock; DR, detergent-resistant; ERK, extracellular signal-regulated kinase; PLC, phospholipase C; LAT, linker for activation of T cells. Back


   ACKNOWLEDGMENTS
 
We thank Drs. Atsushi Koito and Takeo Ohsugi for kindly providing MT1, MT4, and TL-Om1 cell lines, Dr. Xin Lin for the JPM50.6 cell line and Myc-Carma1 construct, and Dr. Susan Nyland (Penn State Cancer Institute) for the MT2, OS-P2, and FC36 cell lines. We also thank Drs. Thomas Loughran, Shao-cong Sun, and Susan Nyland for stimulating discussions about this work.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Hotchkiss, R. S., and Nicholson, D. W. (2006) Nat. Rev. Immunol. 6, 813-822[CrossRef][Medline] [Order article via Infotrieve]
  2. Wang, S. D., Huang, K. J., Lin, Y. S., and Lei, H. Y. (1994) J. Immunol. 152, 5014-5021[Abstract]
  3. Guzhova, I., and Margulis, B. (2006) Int. Rev. Cytol. 254, 101-149[Medline] [Order article via Infotrieve]
  4. Yenari, M. A., Liu, J., Zheng, Z., Vexler, Z. S., Lee, J. E., and Giffard, R. G. (2005) Ann. N. Y. Acad. Sci. 1053, 74-83[CrossRef][Medline] [Order article via Infotrieve]
  5. Beere, H. M., Wolf, B. B., Cain, K., Mosser, D. D., Mahboubi, A., Kuwana, T., Tailor, P., Morimoto, R. I., Cohen, G. M., and Green, D. R. (2000) Nat. Cell Biol. 2, 469-475[CrossRef][Medline] [Order article via Infotrieve]
  6. Saleh, A., Srinivasula, S. M., Balkir, L., Robbins, P. D., and Alnemri, E. S. (2000) Nat. Cell Biol. 2, 476-483[CrossRef][Medline] [Order article via Infotrieve]
  7. Ravagnan, L., Gurbuxani, S., Susin, S. A., Maisse, C., Daugas, E., Zamzami, N., Mak, T., Jäättelä, M., Penninger, J. M., Garrido, C., and Kroemer, G. (2001) Nat. Cell Biol. 3, 839-843[CrossRef][Medline] [Order article via Infotrieve]
  8. Tran, S. E., Meinander, A., Holmström, T. H., Rivero-Müller, A., Heiskanen, K. M., Linnau, E. K., Courtney, M. J., Mosser, D. D., Sistonen, L., and Eriksson, J. E. (2003) Cell Death Differ. 10, 1137-1147[CrossRef][Medline] [Order article via Infotrieve]
  9. Ran, R., Lu, A., Zhang, L., Tang, Y., Zhu, H., Xu, H., Feng, Y., Han, C., Zhou, G., Rigby, A. C., and Sharp, F. R. (2004) Genes Dev. 18, 1466-1481[Abstract/Free Full Text]
  10. Clemons, N. J., and Anderson, R. L. (2006) Cell Stress Chaperones 11, 343-355[CrossRef][Medline] [Order article via Infotrieve]
  11. Feng, X., Bonni, S., and Riabowol, K. (2006) Mol. Cell. Biol. 26, 9244-9255[Abstract/Free Full Text]
  12. Karin, M., and Greten, F. R. (2005) Nat. Rev. Immunol. 5, 749-759[CrossRef][Medline] [Order article via Infotrieve]
  13. Schulze-Luehrmann, J., and Ghosh, S. (2006) Immunity 25, 701-715[CrossRef][Medline] [Order article via Infotrieve]
  14. Perkins, N. D. (2007) Nat. Rev. Mol. Cell Biol. 8, 49-62[CrossRef][Medline] [Order article via Infotrieve]
  15. Khoshnan, A., Bae, D., Tindell, C. A., and Nel, A. E. (2000) J. Immunol. 165, 6933-6940[Abstract/Free Full Text]
  16. Sebald, A., Mattioli, I., and Schmitz, M. L. (2005) Eur. J. Immunol. 35, 318-325[CrossRef][Medline] [Order article via Infotrieve]
  17. Bi, K., Tanaka, Y., Coudronniere, N., Sugie, K., Hong, S., van Stipdonk, M. J., and Altman, A. (2001) Nat. Immunol. 2, 556-563[CrossRef][Medline] [Order article via Infotrieve]
  18. Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., and Littman, D. R. (2000) Nature. 404, 402-407[CrossRef][Medline] [Order article via Infotrieve]
  19. Wang, D., You, Y., Case, S. M., McAllister-Lucas, L. M., Wang, L., DiStefano, P. S., Nuñez, G., Bertin, J., and Lin, X. (2002) Nat. Immunol. 3, 830-835[CrossRef][Medline] [Order article via Infotrieve]
  20. Zhou, H., Wertz, I., O'Rourke, K., Ultsch, M., Seshagiri, S., Eby, M., Xiao, W., and Dixit, V. M. (2004) Nature 427, 167-171[CrossRef][Medline] [Order article via Infotrieve]
  21. Tani-ichi, S., Maruyama, K., Kondo, N., Nagafuku, M., Kabayama, K., Inokuchi, J., Shimada, Y., Ohno-Iwashita, Y., Yagita, H., Kawano, S., and Kosugi, A. (2005) Int. Immunol. 17, 749-758[Abstract/Free Full Text]
  22. Kabouridis, P. S. (2006) Mol. Memb. Biol. 23, 49-57[CrossRef][Medline] [Order article via Infotrieve]
  23. Rouquette-Jazdanian, A. K., Pelassy, C., Breittmayer, J. P., and Aussel, C. (2006) Cell. Signal. 18, 105-122[CrossRef][Medline] [Order article via Infotrieve]
  24. Chen, G., Cao, P., and Goeddel, D. V. (2002) Mol. Cell 9, 401-410[CrossRef][Medline] [Order article via Infotrieve]
  25. Prajapati, S., Verma, U., Yamamoto, Y., Kwak, Y. T., and Gaynor, R. B. (2004) J. Biol. Chem. 279, 1739-1746[Abstract/Free Full Text]
  26. Kray, A. E., Carter, R. S., Pennington, K. N., Gomez, R. J., Sanders, L. E., Llanes, J. M., Khan, W. N., Ballard, D. W., and Wadzinski, B. E. (2005) J. Biol. Chem. 280, 35974-35982[Abstract/Free Full Text]
  27. He, K. L., and Ting, A. T. (2002) Mol. Cell. Biol. 22, 6034-6045[Abstract/Free Full Text]
  28. Reiley, W., Zhang, M., Wu, X., Granger, E., and Sun, S. C. (2005) Mol. Cell. Biol. 25, 3886-3895[Abstract/Free Full Text]
  29. Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., and Courtois, G. (2003) Nature 424, 801-805[CrossRef][Medline] [Order article via Infotrieve]
  30. Brummelkamp, T. R., Nijman, S. M., Dirac, A. M., and Bernards, R. (2003) Nature. 424, 797-801[CrossRef][Medline] [Order article via Infotrieve]
  31. Cheng, H., Cenciarelli, C., Nelkin, G., Tsan, R., Fan, D., Cheng-Mayer, C., and Fidler, I. J. (2005) Mol. Cell. Biol. 25, 44-59[Abstract/Free Full Text]
  32. Schilling, B., De-Medina, T., Syken, J., Vidal, M., and Münger, K. (1998) Virology 247, 74-85[CrossRef][Medline] [Order article via Infotrieve]
  33. Cheng, H., Cenciarelli, C., Shao, Z., Vidal, M., Parks, W. P., Pagano, M., and Cheng-Mayer, C. (2001) Curr. Biol. 11, 1771-1775[CrossRef][Medline] [Order article via Infotrieve]
  34. Sarkar, S., Pollack, B. P., Lin, K. T., Kotenko, S. V., Cook, J. R., Lewis, A., and Pestka, S. (2001) 276, 49034-49042
  35. Ciocca, D. R., and Calderwood, S. K. (2005) Cell Stress Chaperones. 10, 86-103[CrossRef][Medline] [Order article via Infotrieve]
  36. Aghdassi, A., Phillips, P., Dudeja, V., Dhaulakhandi, D., Sharif, R., Dawra, R., Lerch, M. M., and Saluja, A. (2007) Cancer Res. 67, 616-625[Abstract/Free Full Text]
  37. Jost, P. J., and Ruland, J. (2007) Blood 109, 2700-2707[Abstract/Free Full Text]
  38. Tang, X., Liu, D., Shishodia, S., Ozburn, N., Behrens, C., Lee, J. J., Hong, W. K., Aggarwal, B. B., and Wistuba, I. I. (2006) Cancer 107, 2637-2646[Medline] [Order article via Infotrieve]
  39. Nakashima, H., Nakamura, M., Yamaguchi, H., Yamanaka, N., Akiyoshi, T., Koga, K., Yamaguchi, K., Tsuneyoshi, M., Tanaka, M., and Katano, M. (2006) Cancer Res. 66, 7041-7049[Abstract/Free Full Text]
  40. Park, B. K., Zhang, H., Zeng, Q., Dai, J., Keller, E. T., Giordano, T., Gu, K., Shah, V., Pei, L., Zarbo, R. J., McCauley, L., Shi, S., Chen, S., and Wang, C. Y. (2007) Nat. Med. 13, 62-69[CrossRef][Medline] [Order article via Infotrieve]
  41. Sweeney, C., Li, L., Shanmugam, R., Bhat-Nakshatri, P., Jayaprakasan, V., Baldridge, L. A., Gardner, T., Smith, M., Nakshatri, H., and Cheng, L. (2004) Clin. Cancer Res. 10, 5501-5507[Abstract/Free Full Text]
  42. Hara, H., Bakal, C., Wada, T., Bouchard, D., Rottapel, R., Saito, T., and Penninger, J. M. (2004) J. Exp. Med. 200, 1167-1177[Abstract/Free Full Text]
  43. Pomerantz, J. L., Denny, E. M., and Baltimore, D. (2002) EMBO J. 21, 5184-5194[CrossRef][Medline] [Order article via Infotrieve]
  44. Wang, D., Matsumoto, R., You, Y., Che, T., Lin, X. Y., Gaffen, S. L., and Lin, X. (2004) Mol. Cell. Biol. 24, 164-171[Abstract/Free Full Text]
  45. Abboushi, N., El-Hed, A., El-Assaad, W., Kozhaya, L., El-Sabban, M. E., Bazarbachi, A., Badreddine, R., Bielawska, A., Usta, J., and Dbaibo, G. S. (2004) J. Immunol. 173, 3193-3200[Abstract/Free Full Text]
  46. Gaide, O., Favier, B., Legler, D. F., Bonnet, D., Brissoni, B., Valitutti, S., Bron, C., Tschopp, J., and Thome, M. (2002) Nat. Immunol. 3, 836-843[CrossRef][Medline] [Order article via Infotrieve]
  47. Drevot, P., Langlet, C., Guo, X. J., Bernard, A. M., Colard, O., Chauvin, J. P., Lasserre, R., and He, H. T. (2002) EMBO J. 21, 1899-1908[CrossRef][Medline] [Order article via Infotrieve]
  48. Su, T. T., Guo, B., Kawakami, Y., Sommer, K., Chae, K., Humphries, L. A., Kato, R. M., Kang, S., Patrone, L., Wall, R., Teitell, M., Leitges, M., Kawakami, T., and Rawlings, D. J. (2002) Nat. Immunol. 3, 780-786[Medline] [Order article via Infotrieve]
  49. Manicassamy, S., Gupta, S., and Sun, Z. (2006) Cell. Mol. Immunol. 3, 263-270[Medline] [Order article via Infotrieve]
  50. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., and Lusso, P. (1995) Science 270, 1811-1815[Abstract/Free Full Text]
  51. Lairmore, M. D., Roberts, B., Frank, D., Rovnak, J., Weiser, M. G., and Cockerell, G. L. (1992) Int. J. Cancer 50, 124-130[Medline] [Order article via Infotrieve]
  52. Cheng, H., Langley, R. R., Wu, Q., Wu, W., Feng, J., Tsan, R., Fan, D., and Fidler, I. J. (2005) Neoplasia 7, 1065-1072[CrossRef][Medline] [Order article via Infotrieve]
  53. Jiang, Y., and Cheng, H. (2007) Leuk. Res. 31, 541-545[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/18/12489    most recent
M707988200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yan, G.
Right arrow Articles by Cheng, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yan, G.
Right arrow Articles by Cheng, H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement